PUNC inhibitors represent a class of chemical compounds designed to target and modulate the activity of specific protein domains associated with a variety of cellular processes, particularly those involved in post-translational modifications. The term "PUNC" typically refers to a conserved region within proteins, such as ubiquitin or ubiquitin-like domains, which play a critical role in regulating protein stability, signaling, and degradation through the ubiquitin-proteasome system. By inhibiting the function of these domains, PUNC inhibitors can interfere with the proper ubiquitination or deubiquitination of target proteins, thereby altering their fate within the cell. The precise chemical structures of PUNC inhibitors are designed to bind selectively to these conserved regions, often by mimicking the natural substrates or by allosteric inhibition mechanisms that disrupt the interaction between the protein and its regulators.
The development of PUNC inhibitors has involved a detailed understanding of protein-ligand interactions and structure-activity relationships. Researchers focus on designing molecules that have high affinity and specificity for the target protein domains, often using techniques such as high-throughput screening, X-ray crystallography, and molecular docking to optimize the interactions. The inhibitors themselves may be small organic molecules or peptide-based compounds, depending on the nature of the binding site and the biochemical environment in which they are expected to act. Inhibition of the PUNC domains is not only of interest in studying protein homeostasis but also offers insights into the regulation of complex intracellular signaling pathways, where post-translational modifications like ubiquitination act as critical control points. This chemical class continues to be a focus of research due to its role in fundamental biochemical processes.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Inhibits Rac1, a GTPase involved in cell signaling and cytoskeletal organization. This could indirectly influence signaling pathways where Punc is involved. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, affecting cell signaling pathways that could be relevant to Punc's function in cellular communication or adhesion. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor, potentially affecting MAPK/ERK pathways involved in cell signaling and possibly influencing Punc-related pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, which could impact cell signaling pathways related to the function of immunoglobulin superfamily members like Punc. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
A Src family kinase inhibitor, which might affect signaling pathways related to cell adhesion and communication, possibly impacting Punc's function. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
An inhibitor of N-WASP, involved in actin polymerization and cellular architecture, potentially influencing pathways where Punc is involved. | ||||||
Cilengitide | 188968-51-6 | sc-507335 | 5 mg | $215.00 | ||
A selective integrin antagonist, affecting cell adhesion and signaling, potentially impacting processes where Punc plays a role. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A broad-spectrum tyrosine kinase inhibitor, potentially affecting signaling pathways relevant to Punc's function in cellular communication. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, involved in cytoskeletal dynamics, which could indirectly influence Punc's role in cell signaling or adhesion. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
A tyrosine kinase inhibitor, known for its effect on BCR-ABL, but also affecting other kinases, potentially influencing signaling pathways involving Punc. | ||||||